B. Braun Medical
As of the edition of 20 October 2026, B. Braun Medical runs 76 drugs, 76 of them marketed.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Family history
The records place 3 company names in this family.
- Mcgaw Inc: acquired in 1997; successor B. Braun Medical Inc.
Drugs by status
| Status | Count |
|---|---|
| Marketed | 76 |
| Total | 76 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Lidocaine | none listed | 2 |
| Acetaminophen | none listed | 17 |
| Propofol | none listed | 0 |
| Cholecalciferol | none listed | 2 |
| Sodium chloride | none listed | 0 |
| Metronidazole | none listed | 0 |
| Folic acid | none listed | 0 |
| Ascorbic acid | none listed | 0 |
| Heparin | none listed | 5 |
| Rocuronium | none listed | 0 |
| Alcohol | none listed | 0 |
| Dextrose | none listed | 0 |
| Sodium bicarbonate | none listed | 0 |
| Meropenem | none listed | 0 |
| Ceftriaxone | none listed | 0 |
| Calcium | none listed | 0 |
| Cefazolin | none listed | 0 |
| Cyanocobalamin | none listed | 0 |
| Theophylline anhydrous | none listed | 2 |
| Mannitol | none listed | 0 |
| Pyridoxine | none listed | 0 |
| Water | none listed | 0 |
| Arginine | none listed | 0 |
| Magnesium | none listed | 0 |
| Ceftazidime | none listed | 0 |
A route B row is one company at one target. 51 more marketed drugs are not listed here.